HomeNewsWorldOver 900 economists, including Nobel Laureates, sign open letter urging Americans to vote against Donald Trump
Trending Topics

Over 900 economists, including Nobel Laureates, sign open letter urging Americans to vote against Donald Trump

The letter will be updated until November 3. As of October 28, the letter has 907 signatories including 2020 Nobel Prize winner Paul Milgrom, 2016 winner Oliver Hart and 2012 winner Alvin Roth, besides George Akerlof – Nobel Laureate and husband of former US Fed Chief Janet Yellen

October 28, 2020 / 14:37 IST
Story continues below Advertisement
US President Donald Trump (File image: AP Photo/Alex Brandon)
US President Donald Trump (File image: AP Photo/Alex Brandon)

Over 900 economists, including Nobel Laureates, have signed an open letter urging Americans to oppose the re-election of US President Donald Trump. The letter will be updated until November 3.

As of October 28, the letter has 907 signatories, including 2020 Nobel Prize winner Paul Milgrom, 2016 winner Oliver Hart and 2012 winner Alvin Roth. Also on the signatory list is George Akerlof – Nobel Laureate and husband of former US Federal Reserve Chairman Janet Yellen.

Story continues below Advertisement

On the economy, the signees 'strongly urged' voters not to re-elect Trump listing his “chaotic and ineffective approach to negotiation with trade partners,” which they claim has harmed American farmers and interrupted supply chains.

“He claimed to have the unique ability to generate growth (in real GDP) of between 4 percent and 6 percent, but never surpassed 2.9 percent in his first three years in office,” the letter pointed out, adding that Goldman Sachs and Moody’s Analytics’ analysts have backed Joe Biden’s economic plans.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show